A cost analysis for transplantation and options post-Medicare.
The health care issue related to Medicare coverage of immunosuppressant medications has major implications for the medical professional and transplant recipient. Based on cost containment analysis, transplantation is the least expensive route to treat ESRD and justifies support for these bills in Congress to eliminate the time constraints of Medicare payment of immunosuppressant medications. Members of the renal health care community need to be active in the political arena of health care reformation and present their views to policymakers.